Company: TVRD
Filing Date: 2025-01-21
Form Type: 425
Source: 0001104659-25-004749
Chunk: 0

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-21
Form: 425
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
January 16, 2025

CARA THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)</div>

| Delaware                                                           |     | 001-36279   |     |         75-3175693 |
| (state or other jurisdiction                                       
 of incorporation)                                                  |     | -Commission 
 File Number |     |   -I.R.S. Employer 
 Identification No. |
| 400 Atlantic Street                                                
 Suite 500                                                          
 Stamford, CT                                                       |     |             |     |              06901 |
| (Address of principal executive offices)                           |     |             |     |          -Zip Code |
| Registrant's telephone number, including area code: (203) 406-3700 |     |             |     |                    |

<div align='center'>Not applicable

(Former name or former address, if changed since last report.)</div>

Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(seeGeneral Instruction A.2. below):

| x | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |

| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |

| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |

| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title                                    
 of each class                            | Trading 
 Symbol  | Name                       
 of each exchange           
 on which registered        |
| Common Stock, $0.001 par value per share | CARA    | The Nasdaq  Capital Market |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of